hase III trials in schizophrenia and bipolar mania, we now have positive Phase IIb studies for cariprazine in both bipolar depression and major depressive disorder. Our goal is to continue developing cariprazine for patients with a broad range of psychiatric conditions, said Marco Taglietti, M.D.,
Date: Mar 31, 2014
Category: Health
Source: Google
Richter, Forest Announce Positive IIb Results for Cariprazine for Bipolar ...
completed Phase III trials in schizophrenia and bipolar mania, we now have positive Phase IIb studies for Cariprazine in both bipolar depression and major depressive disorder. Our goal is to continue developing Cariprazine for patients with a broad range of psychiatric conditions," said Marco Taglietti, M.
Date: Mar 31, 2014
Category: Health
Source: Google
Forest, Richter Schizophrenia Drug Met Clinical Trial Goals
By successfully meeting the primary endpoint in each of these studies, we now have three positive schizophrenia trials and three positive bipolar mania trials, said Marco Taglietti, the senior vice president for research and development at New York-based Forest.
"Today shows our commitment to the COPD community with a second product to treat a very common disease," said Dr. Marco Taglietti, senior vice president for research and development at Forest Laboratories.